Trace Genomics, Inc. — Form D/A

Trace Genomics, Inc. of Redwood City, CA, a company, filed a Form D amendment with the SEC on 2020-07-10. The offering totals $17.2M, of which $17.2M was reported sold. Industry: Other.

Offering

• Filed: 2020-07-10
• Form: D/A
• Accession: 0001741875-20-000002
• Industry: Other
• Exemptions: 06b
• Total offering: $17.2M
• Amount sold: $17.2M
• Investors: 14
• Date of first sale: 2020-05-20
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-368042

Issuer

• Name: Trace Genomics, Inc.
• CIK: 0001741875
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 303 Twin Dolphin Drive, Redwood City, CA, 94065
• Phone: (844) 672-5749

Officers, directors & promoters (11)

Other filings by this issuer (4)

More

• CIK 1741875 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search